H.C. Wainwright & Co. Initiates MedinCell’s Coverage with a “Buy” Recommendation
June 28, 2024
Previous PostMedincell to Present Data Showing Enhanced Potential of Tumor-Targeting Monoclonal Antibody in Melanoma Using BEPO® Technology at he CRS Annual Meeting
Next PostMedincell joins the Euronext Tech Leaders
